Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Fricker

Showing results (181-190 of 193) with videos related to

Pageof 20
Sort By:
Journal of Medicinal Chemistry|August 8, 2025
Exploration of the Neuromodulatory Properties of Fyn and GSK-3β Kinases Exploiting 7-Azaindole-Based InhibitorsGiambattista Marotta, Francesca Massenzio, Jose Ortega, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 11, 2026
Balancing Stealth and Targetability: cCPP- and PEG-Modified Liposomes for the Targeted Delivery of Anti-HER2 NanobodiesGiulia Pander, Maria Del Pilar Palacios Cisneros, Clara Certa, et al.
Journal of Neurochemistry|April 1, 2006
Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiencySven W Sauer, Jürgen G Okun, Gert Fricker, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 4, 2025
Brain delivery of a neurotrophic peptide derived from secreted amyloid precursor protein APPsα as a therapeutic strategy for Alzheimer's diseaseLena Rehra, Susanne Erdinger, Lelia Wagner, et al.
Nature Reviews. Neuroscience|February 19, 2011
Engaging neuroscience to advance translational research in brain barrier biologyEdward A Neuwelt, Björn Bauer, Christoph Fahlke, et al.
Fluids and Barriers of the CNS|November 8, 2017
Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017John Greenwood, Margareta Hammarlund-Udenaes, Hazel C Jones, et al.
Fluids and Barriers of the CNS|January 14, 2018
Correction to: Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017John Greenwood, Margareta Hammarlund-Udenaes, Hazel C Jones, et al.
Fluids and Barriers of the CNS|December 20, 2023
Characterization of an iPSC-based barrier model for blood-brain barrier investigations using the SBAD0201 stem cell lineBurak Ozgür, Elena Puris, Andreas Brachner, et al.
Pharmaceuticals (Basel, Switzerland)|January 6, 2019
Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography ImagingRalf Schirrmacher, Justin J Bailey, Andrew V Mossine, et al.
ACS Chemical Neuroscience|August 6, 2025
Design, Synthesis and Biological Evaluation of Chromeno[3,4-<i>b</i>]xanthones as Multifunctional Agents for Alzheimer's DiseaseDaniela Malafaia, Natércia F Brás, Anna Sampietro, et al.
Pageof 20

Showing results (181-190 of 193) with videos related to

Sort By:
Pageof 20
Journal of Medicinal Chemistry|August 8, 2025
Exploration of the Neuromodulatory Properties of Fyn and GSK-3β Kinases Exploiting 7-Azaindole-Based InhibitorsGiambattista Marotta, Francesca Massenzio, Jose Ortega, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 11, 2026
Balancing Stealth and Targetability: cCPP- and PEG-Modified Liposomes for the Targeted Delivery of Anti-HER2 NanobodiesGiulia Pander, Maria Del Pilar Palacios Cisneros, Clara Certa, et al.
Journal of Neurochemistry|April 1, 2006
Intracerebral accumulation of glutaric and 3-hydroxyglutaric acids secondary to limited flux across the blood-brain barrier constitute a biochemical risk factor for neurodegeneration in glutaryl-CoA dehydrogenase deficiencySven W Sauer, Jürgen G Okun, Gert Fricker, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|November 4, 2025
Brain delivery of a neurotrophic peptide derived from secreted amyloid precursor protein APPsα as a therapeutic strategy for Alzheimer's diseaseLena Rehra, Susanne Erdinger, Lelia Wagner, et al.
Nature Reviews. Neuroscience|February 19, 2011
Engaging neuroscience to advance translational research in brain barrier biologyEdward A Neuwelt, Björn Bauer, Christoph Fahlke, et al.
Fluids and Barriers of the CNS|November 8, 2017
Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017John Greenwood, Margareta Hammarlund-Udenaes, Hazel C Jones, et al.
Fluids and Barriers of the CNS|January 14, 2018
Correction to: Current research into brain barriers and the delivery of therapeutics for neurological diseases: a report on CNS barrier congress London, UK, 2017John Greenwood, Margareta Hammarlund-Udenaes, Hazel C Jones, et al.
Fluids and Barriers of the CNS|December 20, 2023
Characterization of an iPSC-based barrier model for blood-brain barrier investigations using the SBAD0201 stem cell lineBurak Ozgür, Elena Puris, Andreas Brachner, et al.
Pharmaceuticals (Basel, Switzerland)|January 6, 2019
Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography ImagingRalf Schirrmacher, Justin J Bailey, Andrew V Mossine, et al.
ACS Chemical Neuroscience|August 6, 2025
Design, Synthesis and Biological Evaluation of Chromeno[3,4-<i>b</i>]xanthones as Multifunctional Agents for Alzheimer's DiseaseDaniela Malafaia, Natércia F Brás, Anna Sampietro, et al.
Pageof 20